Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Antibiotic Resistant Infections
$31,982N01FY2025AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
View original record on NIH RePORTER →